Penny Stocks To Watch: Revive Therapeutics Ltd. Mail Are These Cheap Stocks On Your Coronavirus Watch List This Week? Whether youre looking for penny stocks under 10 cents or ones that are a bit higher in price, the same goals are in place. The whole point of trading is to make money and when it comes to penny stocks, those gains can come quickly. Obviously, simple math suggests that the lower the price, the smaller the price move needs to be in order to see larger returns. Herein lies the risk/reward scenario. Just as small a price move creates big gains it can also equate to hefty losses. Lets say youve got a few penny stocks in front of you. Some are stocks under $5 maybe trading around $4, for example. Others are these lower-priced penny stocks under 10 cents. If your $4 stock moves up or down by 4 cents, the percentage change is 1%; nominal. However, if your penny stocks under 10 cents experience a move of 4 cents, youre talking about 40% or more. Now, a lot of this depends on the shares structure as well. Ive seen penny stocks with huge floats take months to move up or down 4 cents. The underlying stock was trading around 10 cents. Ive also seen low float penny stocks closer to $5 run 100% or more in a single day. If you remember KODK from earlier this year, we saw the penny stock jump from around $2.13 to highs of $60 in less than a week. It also came down just as quickly. At the end of the day, the price of penny stocks is just one aspect to account for in your trading strategy. With this in mind, lets take a look at a few penny stocks that have started to trend higher this week. Penny Stocks To Watch: Revive Therapeutics Ltd. Revive Therapeutics Ltd. (RVVTF Stock Report)(RVV) has chosen to focus on using existing drugs to address COVID and its side effects. While the company has diversified its offerings across a number of biotech indications, the recent focus has been on its coronavirus treatment. The companys Bucillamine is becoming a standout among coronavirus treatment candidates. Revive also affirmed that it may unrealized potential for the treatment of influenza with both proven safety and proven mechanism of action similar to that of something known as NAC, or N-acetylcysteine. NAC is important for a variety of health reasons including replenishing the most powerful antioxidant in your body, glutathione. These amino acids also help with chronic respiratory conditions, organ vitality, fertility and brain health. Earlier this year, the FDA recommended that Revive proceed directly into a Phase 3 confirmatory clinical trial to evaluate Bucillamine for the treatment of patients with mild-moderate COVID-19 in order to ensure expeditious evaluation of the safety and efficacy of Bucillamine. Fast-forward a bit and Revive Therapeutics Phase 3 clinical trial protocol received IRB approval. Michael Frank, CEO of Revive Therapeutics stated that with the IRB approval of the Phase 3 study protocol for Covid-19, we can recruit U.S. clinical sites efficiently, allowing us to move forward with providing Bucillamine to patients under our IND that was approved by the FDA. With a Phase 3 coronavirus candidate in toe, will RVVTF stock be on your watch list in September? GOOD LUCK top-penny-stocks-under-3-dollars-to-watch-this-week-september-9-2020